Delta-Fly Pharma (4598) Income Statement & Earnings

248
+15+6.44%

20min DelayMarket Closed Jan 23 15:30 JST

3.02BMarket Cap-1.27P/E (Static)

Delta-Fly Pharma (4598) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 31, 2025

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

Total revenue

Cost of revenue

Gross profit

Operating expense

21.71%1.71B

6.66%1.4B

56.88%454.07M

-14.18%355.94M

3.42%317.87M

-9.43%275.58M

4.31%1.32B

-11.94%289.44M

48.81%414.74M

23.28%307.37M

Selling and administrative expenses

-5.12%270.27M

-6.29%284.85M

5.99%76.46M

-9.74%71.13M

2.33%68.19M

-20.07%69.07M

-5.21%303.98M

1.12%72.14M

9.09%78.81M

2.35%66.64M

-General and administrative expense

-5.12%270.27M

-6.29%284.85M

5.99%76.46M

-9.74%71.13M

2.33%68.19M

-20.07%69.07M

-5.21%303.98M

1.12%72.14M

9.09%78.81M

2.35%66.64M

Research and development costs

28.55%1.44B

10.55%1.12B

73.77%377.61M

-15.22%284.81M

3.72%249.68M

-5.21%206.51M

7.55%1.01B

-15.55%217.3M

62.71%335.93M

30.67%240.73M

Operating profit

-21.71%-1.71B

-6.66%-1.4B

-56.88%-454.07M

14.18%-355.94M

-3.42%-317.87M

9.43%-275.58M

-36.86%-1.32B

-124.95%-289.44M

-48.81%-414.74M

-23.28%-307.37M

Net non-operating interest income (expenses)

47.45%-9.27M

-320.65%-17.64M

100.64%8K

-471.86%-16.87M

-14.29%6K

-786K

-131.84%-4.19M

-14,000.00%-1.25M

-2.95M

-30.00%7K

Non-operating interest income

2,307.14%337K

7.69%14K

33.33%8K

--0

-14.29%6K

--0

-81.43%13K

-33.33%6K

--0

-30.00%7K

Total other finance cost

-45.58%9.61M

319.68%17.66M

--0

--16.87M

--0

--786K

123.90%4.21M

--1.26M

----

Net investment income

79.62%-1.18M

0.02%-5.79M

-323.85%-1.8M

-70.03%824K

80.34%-1.13M

-2.45%-3.68M

-533.15%-5.79M

374.74%805K

588.28%2.75M

-1,081.11%-5.75M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

Special income (charges)

Other non-operating income (expenses)

1,000.00%11K

-96.88%1K

-73.33%32K

24K

Income before tax

-20.45%-1.72B

-7.63%-1.43B

-57.27%-455.87M

10.35%-371.99M

-1.88%-319M

9.03%-280.04M

-37.52%-1.33B

-124.78%-289.86M

-48.59%-414.94M

-25.39%-313.1M

Income tax

0.00%2.5M

-17.37%2.5M

0.16%626K

-19.35%625K

-23.28%626K

-23.03%625K

-6.46%3.03M

-23.87%625K

-3.73%775K

1.12%816K

Net income

-20.41%-1.72B

-7.57%-1.43B

-57.15%-456.49M

10.37%-372.61M

-1.82%-319.62M

9.07%-280.67M

-37.37%-1.33B

-123.84%-290.49M

-48.44%-415.71M

-25.32%-313.92M

Net income continuous operations

-20.41%-1.72B

-7.57%-1.43B

-57.15%-456.49M

10.37%-372.61M

-1.82%-319.62M

9.07%-280.67M

-37.37%-1.33B

-123.84%-290.49M

-48.44%-415.71M

-25.32%-313.92M

Noncontrolling interests

Net income attributable to the company

-20.41%-1.72B

-7.57%-1.43B

-57.15%-456.49M

10.37%-372.61M

-1.82%-319.62M

9.07%-280.67M

-37.37%-1.33B

-123.84%-290.49M

-48.44%-415.71M

-25.32%-313.92M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-20.41%-1.72B

-7.57%-1.43B

-57.15%-456.49M

10.37%-372.61M

-1.82%-319.62M

9.07%-280.67M

-37.37%-1.33B

-123.84%-290.49M

-48.44%-415.71M

-25.32%-313.92M

Gross dividend payment

Basic earnings per share

1.61%-195.58

15.24%-198.78

-27.88%-56.69

33.37%-50.17

15.66%-48.85

24.39%-43.07

-31.32%-234.51

-85.25%-44.33

-45.70%-75.3

-25.34%-57.92

Diluted earnings per share

1.61%-195.58

15.24%-198.78

-24.30%-56.69

34.60%-50.17

15.67%-48.85

24.39%-43.07

-31.32%-234.51

-90.46%-45.607

-48.43%-76.7079

-25.32%-57.9246

Dividend per share

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Mar 31, 2025	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Cost of revenue
Gross profit
Operating expense	21.71%1.71B	6.66%1.4B	56.88%454.07M	-14.18%355.94M	3.42%317.87M	-9.43%275.58M	4.31%1.32B	-11.94%289.44M	48.81%414.74M	23.28%307.37M
Selling and administrative expenses	-5.12%270.27M	-6.29%284.85M	5.99%76.46M	-9.74%71.13M	2.33%68.19M	-20.07%69.07M	-5.21%303.98M	1.12%72.14M	9.09%78.81M	2.35%66.64M
-General and administrative expense	-5.12%270.27M	-6.29%284.85M	5.99%76.46M	-9.74%71.13M	2.33%68.19M	-20.07%69.07M	-5.21%303.98M	1.12%72.14M	9.09%78.81M	2.35%66.64M
Research and development costs	28.55%1.44B	10.55%1.12B	73.77%377.61M	-15.22%284.81M	3.72%249.68M	-5.21%206.51M	7.55%1.01B	-15.55%217.3M	62.71%335.93M	30.67%240.73M
Operating profit	-21.71%-1.71B	-6.66%-1.4B	-56.88%-454.07M	14.18%-355.94M	-3.42%-317.87M	9.43%-275.58M	-36.86%-1.32B	-124.95%-289.44M	-48.81%-414.74M	-23.28%-307.37M
Net non-operating interest income (expenses)	47.45%-9.27M	-320.65%-17.64M	100.64%8K	-471.86%-16.87M	-14.29%6K	-786K	-131.84%-4.19M	-14,000.00%-1.25M	-2.95M	-30.00%7K
Non-operating interest income	2,307.14%337K	7.69%14K	33.33%8K	--0	-14.29%6K	--0	-81.43%13K	-33.33%6K	--0	-30.00%7K
Total other finance cost	-45.58%9.61M	319.68%17.66M	--0	--16.87M	--0	--786K	123.90%4.21M	--1.26M	----	----
Net investment income	79.62%-1.18M	0.02%-5.79M	-323.85%-1.8M	-70.03%824K	80.34%-1.13M	-2.45%-3.68M	-533.15%-5.79M	374.74%805K	588.28%2.75M	-1,081.11%-5.75M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses)	1,000.00%11K	-96.88%1K	0	0			-73.33%32K	24K	0
Income before tax	-20.45%-1.72B	-7.63%-1.43B	-57.27%-455.87M	10.35%-371.99M	-1.88%-319M	9.03%-280.04M	-37.52%-1.33B	-124.78%-289.86M	-48.59%-414.94M	-25.39%-313.1M
Income tax	0.00%2.5M	-17.37%2.5M	0.16%626K	-19.35%625K	-23.28%626K	-23.03%625K	-6.46%3.03M	-23.87%625K	-3.73%775K	1.12%816K
Net income	-20.41%-1.72B	-7.57%-1.43B	-57.15%-456.49M	10.37%-372.61M	-1.82%-319.62M	9.07%-280.67M	-37.37%-1.33B	-123.84%-290.49M	-48.44%-415.71M	-25.32%-313.92M
Net income continuous operations	-20.41%-1.72B	-7.57%-1.43B	-57.15%-456.49M	10.37%-372.61M	-1.82%-319.62M	9.07%-280.67M	-37.37%-1.33B	-123.84%-290.49M	-48.44%-415.71M	-25.32%-313.92M
Noncontrolling interests
Net income attributable to the company	-20.41%-1.72B	-7.57%-1.43B	-57.15%-456.49M	10.37%-372.61M	-1.82%-319.62M	9.07%-280.67M	-37.37%-1.33B	-123.84%-290.49M	-48.44%-415.71M	-25.32%-313.92M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-20.41%-1.72B	-7.57%-1.43B	-57.15%-456.49M	10.37%-372.61M	-1.82%-319.62M	9.07%-280.67M	-37.37%-1.33B	-123.84%-290.49M	-48.44%-415.71M	-25.32%-313.92M
Gross dividend payment
Basic earnings per share	1.61%-195.58	15.24%-198.78	-27.88%-56.69	33.37%-50.17	15.66%-48.85	24.39%-43.07	-31.32%-234.51	-85.25%-44.33	-45.70%-75.3	-25.34%-57.92
Diluted earnings per share	1.61%-195.58	15.24%-198.78	-24.30%-56.69	34.60%-50.17	15.67%-48.85	24.39%-43.07	-31.32%-234.51	-90.46%-45.607	-48.43%-76.7079	-25.32%-57.9246
Dividend per share
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Amidst the global market turbulence triggered by the US-Europe dispute over Greenland, a single post by Trump instantly reversed market tren Show More

Futubull Options Sir

Jan 19 17:47

Options Weekly 0119 | Greenland tariff standoff, gold and silver surge again, shocking reversal in Fed chair nominee! Watch Intel, Netflix earnings reports

杨杨得億

Jan 20 13:42

The real danger in the 2026 market isn't black swan events, but rather the changes you've become accustomed to ignoring.